Since extracorporeal membrane oxygenation (ECMO) was introduced as a treatment modality for respiratory failure in 1972 by Hill et al., [1] it has provided support to patients with inadequate oxygen delivery for days to weeks. Clinicians have used ECMO to increase oxygen delivery in severe lung disease, ineffective cardiac output from circulatory failure, or combined cardiopulmonary failure. ECMO has typically been applied in rescue situations that were refractory to conventional therapy. A key question is how to organize such case reports or series so that they provide findings that are close to evidence. To cite one example, ECMO complications can arise either from patient factors or ECMO circuit components. Due to the diversity in indicc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
■ Editorial ■
Since extracorporeal membrane oxygenation (ECMO) was introduced as a treatment modality for respiratory failure in 1972 by Hill et al., [1] it has provided support to patients with inadequate oxygen delivery for days to weeks. Clinicians have used ECMO to increase oxygen delivery in severe lung disease, ineffective cardiac output from circulatory failure, or combined cardiopulmonary failure. ECMO has typically been applied in rescue situations that were refractory to conventional therapy. [2] Recently, researchers in the U.S., Germany, and Taiwan reported a rapid increase in the use of ECMO in their countries. [3] [4] [5] Diseases such as the H1N1 pandemic influenza, [6] the development of ECMO technology, [7] and the publication of randomized clinical trials have likely contributed to an increase in the use of ECMO. [8] In contrast to the growing worldwide use of ECMO, evidence of its use in critical care situations is still lacking. [9] In particular, there is not much evidence supporting ECMO use in adult patients with Acute Respiratory Distress Syndrome (ARDS) and there is a paucity of rigorous experiments on its use in these patients. They simplified the analysis by selecting only venoarterial type ECMO and only cardiogenic shock or cardiac arrest patients. They also only included studies that reported complication rates on 10 or more patients.
Enlarging sample size allows a retrospective cohort study publication to be classified as more of a systematic review.
In particular, tertiary referral centers are able to collect and analyze data from many ECMO cases more easily. [18, 19] Because each institution has their own standard circuit, a single center study has the advantage of consistent analysis.
If studies are not conducted at a single center or do not have enough cases, data can be collected from several centers through networks, as in the study by Kanji et al. [20] ECMO case reports are consistently submitted to KJCCM.
Performing studies to collect, categorize, and analyze
ECMO experiences is worth attempting for critical care physicians who are working at a critical care unit. This place of work is a very intimate factor in ECMO research, since many different departments are involved in the ECMO procedure, all of which specialize in intensive or critical care.
Whether a department, an institute, or a society takes the lead, we look forward to the submission of more research beyond simple case reports on ECMO use in the future.
